N04BA01 levodopa
ATC group of level 5 – chemical substance · in plain English: medicines for Parkinson's disease
This site has the patient leaflet or the SPC of 2 medicines in this group.
- 2 prescription only (POM)
Active substance: Levodopa – all medicines with this substance, also in combinations.
Place in the ATC classification
- N Nervous system drugs 4,479 medicines
- N04 Anti-parkinson drugs 315 medicines
- N04B Dopaminergic agents 292 medicines
- N04BA Dopa and dopa derivatives 83 medicines
- N04BA01 levodopa 2 medicines
- N04BA Dopa and dopa derivatives 83 medicines
- N04B Dopaminergic agents 292 medicines
- N04 Anti-parkinson drugs 315 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Inbrija SPC | Prescription only (POM) |
| Inbrija 33 mg inhalation powder, hard capsules SPC | Prescription only (POM) |
Other groups of the same level
- N04BA02 levodopa and decarboxylase inhibitor 40 medicines
- N04BA03 levodopa, decarboxylase inhibitor and COMT inhibitor 41 medicines
Other names of the ATC group
- Czech: N04BA01 Levodopa
- French: N04BA01 lévodopa
- German: N04BA01 Levodopa
- German: N04BA01 Levodopa
- Polish: N04BA01 Lewodopa
- Turkish: N04BA01 levodopa
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group N04BA01
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.